Cardio-Oncology: Vascular Endothelial Growth Factor Inhibitors, Salt, and Macrophages: A Complicated Interaction.
From the Divisions of Cardiovascular Medicine (J.M., A.K.P., N.B.) and Oncology (J.M.), Cardio-Oncology Program (J.M., A.K.P., N.B.), Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. javid.moslehi@vanderbilt.edu.
Javid
J
Moslehi
From the Divisions of Cardiovascular Medicine (J.M., A.K.P., N.B.) and Oncology (J.M.), Cardio-Oncology Program (J.M., A.K.P., N.B.), Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Arvind K
AK
Pandey
From the Divisions of Cardiovascular Medicine (J.M., A.K.P., N.B.) and Oncology (J.M.), Cardio-Oncology Program (J.M., A.K.P., N.B.), Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Nirmanmoh
N
Bhatia
D006801:Humans; D008264:Macrophages; D012965:Sodium Chloride; D017673:Sodium Chloride, Dietary; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D017673:Sodium Chloride, Dietary; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D012965:Sodium Chloride